Note 17 - Segment Reporting - Schedule of Segment Reporting (Details) - USD ($)		3 Months Ended
		Dec. 31, 2019	Dec. 31, 2018		Sep. 30, 2019
Revenues		$ 4,316,000	$ 5,468,000
Other income		340,000	234,000
Segment profit (loss)		1,400,000	1,700,000
Segment Assets (1)		92,509,000	86,100,000	[1]	$ 90,685,000
Operating Segments [Member] | Consumer Receivables [Member]
Revenues		3,100,000	3,500,000
Other income	[2]		100,000
Segment profit (loss)		2,900,000	2,900,000
Segment Assets (1)	[1]	7,200,000	12,000,000
Operating Segments [Member] | GAR Disability Advocates [Member]
Revenues		800,000	1,300,000
Other income	[2]
Segment profit (loss)			400,000
Segment Assets (1)	[1]	1,000,000	1,400,000
Operating Segments [Member] | Personal Injury Claims [Member]
Revenues	[3]	400,000	700,000
Other income	[2],[3]
Segment profit (loss)	[3]	600,000	500,000
Segment Assets (1)	[1],[3]	4,800,000	10,100,000
Corporate, Non-Segment [Member]
Revenues	[4]
Other income	[2],[4]	300,000	100,000
Segment profit (loss)	[4]	(2,100,000)	(2,100,000)
Segment Assets (1)	[1],[4]	$ 79,500,000	$ 62,600,000

[1] Includes other amounts in other line items on the consolidated balance sheet.

[2] Included in other income is approximately $0.6 million and $4.0 million in gain on settlements for the years ended September 30, 2019 and 2018, respectively (see Note 10 - Settlements).

[3] The Company recorded Pegasus as an equity investment in its consolidated financial statements through January 12, 2018. Commencing on January 13, 2018, Sylvave is consolidated in the Company's financial statements. For segment reporting the Company has included its pro-rated share of the earnings and losses from its investment under the Personal Injury Claims segment.

[4] Corporate is not part of the three reportable segments, as certain expenses and assets are not earmarked to any specific operating segment.